Your session is about to expire
← Back to Search
Enhanced PET Scan Techniques for Disease Imaging
N/A
Waitlist Available
Led By Michael V Knopp, MD, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, on average 2-5 years
Awards & highlights
Study Summary
This trial is comparing different ways of processing PET scans to see which is best, as well as generating data for potential clinical trials and comparing PET scans to other imaging techniques.
Who is the study for?
This trial is for men and women aged 18 or older who are already scheduled to receive a standard PET scan at OSU. It's designed to refine PET imaging techniques and compare them with current methods.Check my eligibility
What is being tested?
The study is testing new ways of processing images from PET scans, which could improve how we visualize what's happening inside the body. Participants will have their standard care PET images compared with these new investigational procedures.See study design
What are the potential side effects?
Since this trial involves additional image processing rather than a medical intervention, there are no direct side effects from the procedure itself. However, it includes exposure to radiation typical of standard PET scans.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, on average 2-5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, on average 2-5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
artifacts
image noise
image quality
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Retrospective populationExperimental Treatment1 Intervention
Group II: Prospective populationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PET scan
2016
Completed Phase 2
~650
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,263 Total Patients Enrolled
Ohio State UniversityLead Sponsor
834 Previous Clinical Trials
507,830 Total Patients Enrolled
Michael V Knopp, MD, PhDPrincipal InvestigatorOhio State University
8 Previous Clinical Trials
373 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am unable to understand or sign the consent form.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Prospective population
- Group 2: Retrospective population
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the ceiling for recruitment in this trial?
"Yes, the information displayed on clinicaltrials.gov confirms that this study is actively recruiting patients. The trial was first posted on 1/2/2015 and was most recently edited on 4/15/2022. The study is looking for 700 patients across 1 locations."
Answered by AI
Share this study with friends
Copy Link
Messenger